UPPI LLC (United Pharmacy Partners) Proudly Announces That Thirty-One (31) Nuclear Pharmacy Members & Affiliates Received a Recognition Award from the U.S. Department of Energy


SUWANEE, Ga.–(BUSINESS WIRE)–UPPI LLC (United Pharmacy Partners) is proud to announce that thirty-one (31) nuclear pharmacy members and affiliates have received a Recognition Award from the U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA) from Assistant Deputy Administrator Peter H. Hanlon in recognition of providing radiopharmaceuticals of molybdenum 99/technetium 99m derived from sources with low enriched uranium (LEU).

As part of the “UPPI LEU Walk” campaign, this effort helps to accelerate uptake of supplies of molybdenum 99-derived medical imaging products produced without highly enriched uranium (HEU). Mo-99 is the parent isotope of technenium-99m, the “workhorse” isotope used in about 80% nuclear diagnostic imaging procedures. This supports the Department of Energy efforts to reduce the use of HEU – which could be used in a nuclear device – and establish domestic production of molybdenum-99 without the use of HEU to improve the supply of medical radioisotopes, as codified in the American Medical Isotopes Production Act of 2012. UPPI radiopharmacies have been working with hospitals and imaging centers to embrace the transition to reliable, LEU-based sources of medical isotopes.

Those members receiving the certificate:

AccuRx, Birmingham, AL.

Advance Isotopes of Idaho Chubbuck, ID.

Cox Nuclear Pharmacy Mobile, AL.

East Coast Nuclear Pharmacy Palm Beach Gardens, FL

Heartlight Pharmacy Lima, OH.

Heartlight Pharmacy Worthington, OH.

Intermountain Radiopharmacy Salt Lake City, UT.

IonSouth Diagnostic Pharmacy Dothan, AL.

Lakeshore (TTG) Isotopes, Erie, PA.

Lakeview Diagnostics, Harrison Township, MI.

North Alabama Radiopharmacy, Muscle Shoals, AL.

Nuclear Diagnostic Products, Plainview, NY.

Nuclear Diagnostic Products, Rockaway, NJ.

Nuclear Diagnostic Products of Philadelphia, Cherry Hill. NJ.

NuclearRx, Tulsa, OK.

Oklahoma University Health Science Center Nuclear Pharmacy, Oklahoma City, OK.

Palmetto Isotopes, Ridgeland, SC.

PharmaRX Hawaii, Aiea, HI.

PCI Nuclear, Tempe, AZ.

Pioneer Pharmacy, Baton Rouge, LA.

Radiopharmacy of Indianapolis, Indianapolis, IN.

Radiopharmacy of Paducah, Paducah, KY.

Radiology Services of Northern Virginia, Herndon, VA.

Shertech Pharmacy Charlotte, Charlotte, NC.

Shertech Pharmacy Piedmont, Kernersville, NC.

Shertech Pharmacy Services, Easley, SC.

Specialty Pharmacy Services, Temple, TX.

TTG Isotopes, Pittsburgh, PA.

Unified Healthcare, Louisville, KY.

West Coast Nuclear Pharmacy, Tampa, FL.

Zevacor Molecular, Decatur, IL.

Established in 1998, UPPI is an alliance of independent commercial radiopharmacies and leading non-profit academic medical center radiopharmacies, which are focused on delivering prepared radiopharmaceuticals for diagnostic molecular imaging and therapeutic patient care needs. UPPI national reach provides daily and on-call radiopharmaceuticals in metropolitan, secondary, tertiary, and rural market places. Every day UPPI member and affiliate pharmacies provide over 8,000 unit dose prescriptions for diagnostic imaging and radiotherapy to nuclear medicine physicians, radiologists, nuclear cardiologists and oncologists. The UPPI network includes 83 radiopharmacies and academic radiopharmacies and 10 cyclotrons for the production of Positron Emission Tomography (PET) radiopharmaceuticals.


John Witkowski, 770-205-2651

Business Wire